Back to Search
Start Over
Chemopreventive efficacy of selenomethionine and its role in the antioxidant defense system in 2-acetylaminofluorene-induced hepatocarcinogenesis in rats.
- Source :
-
Journal of experimental therapeutics & oncology [J Exp Ther Oncol] 1996 Jul; Vol. 1 (4), pp. 209-17. - Publication Year :
- 1996
-
Abstract
- Drinking water supplemented with selenium (8 ppm, daily) has been found to be highly effective in reducing tumor incidence and preneoplastic foci in 2-acetylaminofluorene (2-AAF) induced hepatocarcinogenesis in Sprague-Dawley male rats. Glutathione and several enzymes in liver tissue associated with antioxidant defense mechanisms, viz., catalase, glutathione-S-transferase, glutathione peroxidase, glutathione reductase and superoxide dismutase were investigated from hyperplastic nodules and non-nodular surrounding parenchyma. Treatment with selenomethionine either on initiation, or on selection/promotion, or during the entire experiment showed that selenom-ethionine was most effective when it was used as a supplement during the entire experiment, in terms of the antioxidant defense system and in reducing tumor incidence. Our results also confirm that selenium is particularly effective in limiting the action of 2-AAF during the initiation phase of hepatocarcinogenesis.
- Subjects :
- Animals
Catalase metabolism
Glutathione metabolism
Glutathione Transferase metabolism
Lipid Peroxides metabolism
Liver pathology
Liver Neoplasms, Experimental chemically induced
Liver Neoplasms, Experimental enzymology
Male
Microsomes, Liver drug effects
Microsomes, Liver enzymology
Microsomes, Liver metabolism
Rats
Rats, Sprague-Dawley
Superoxide Dismutase metabolism
Thiobarbituric Acid Reactive Substances
2-Acetylaminofluorene toxicity
Antioxidants therapeutic use
Carcinogens toxicity
Liver Neoplasms, Experimental prevention & control
Selenomethionine therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1359-4117
- Volume :
- 1
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of experimental therapeutics & oncology
- Publication Type :
- Academic Journal
- Accession number :
- 9414405